Molecular mechanism of pathogenesis of Dengue virus: Entry and fusion with target cell

Indian Journal of Clinical Biochemistry

Volumn 20, Issue 2, 2005, Pages 92-103

  Seema, ^a   Jain, S K ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cell surface receptors; Dengue fever; Glycosaminoglycans; Heparan sulfate; Viral attachment

Indexed keywords

CELL SURFACE RECEPTOR; ENVELOPE PROTEIN; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; RECOMBINANT PROTEIN; SIALIDASE; UNCLASSIFIED DRUG; VIRUS ATTACHMENT PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; BINDING SITE; DENGUE; DENGUE VIRUS; DISEASE TRANSMISSION; FEVER; FLAVIVIRUS; HUMAN; HUMAN CELL; INDIA; INTERNALIZATION; MONOCYTE; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; RECEPTOR GENE; REVIEW; TARGET CELL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ANIMALIA; DENGUE VIRUS; FLAVIVIRUS;

EID: 24044451205     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02867407     Document Type: Review

References (81)

1. Acevedo, J., Casanova, M.F., Antonini, A.C. and Morales, H. (1982) Acute neuritis associated with dengue. Lancet I, 1357.
2. Albrecht, P. (1968) Pathogenesis of neurotropic arbovirus infection. Current Topics in Microbiology and Immunology 43, 44-91.
3. Allison, S.L., Stadler, K., Mandl, C.W. and Heinz, F.X. (1995) Synthesis and secretion of recombinant TBV protein E in soluble and particulate form. J. Virol. 73, 5605-5612.
4. Aden, D.P., Fogel, A., Plotkin, S., Damjanov, I., and Knowles, B.B. (1979) Controlled synthesis of HbsAg in differentiated human liver carcinoma-derived cell line. Nature, London. 282, 615-616.
5. Anderson, R., King, A.D. and Innis, B.L. (1992) Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J. Gen. Virol. 73, 2155-2159.
6. Barth, O.M. (1992) Replication of dengue viruses in mosquito cell cultures - a model from ultrastructural observations. Mem. Inst. Oswaldo Cruz. 87, 565-574.
7. Bhamamarapravati, N. and Halstead, S.B. (1964) Studies on dengue virus in immunofluorescent localization of virus in mouse tissue. Archives of Pathology 77, 538-543.
8. Bielefeldt-Ohmann H., Michelle Meyer, Fitzpatrick, D. R. and Mackenzie, J.S. (2001) Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res. 60, 7381-7389.
9. Bielefeldt-Ohman, H. (1998) Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B-lymphocytes. Virus Res. 57, 63-79.
10. Bonner, S. M., and O'Sullivan, M.A. (1998) Endothelial cell monolayers as a model system to investigate dengue shock syndrome. J. Virol. Methods 71, 159-167.
11. Chambers, T.J., Hahn, C.S., Galler, R. and Rice, C.M. (1990) Flavivirus genome organisation, expression and replication. Annu. Rev. Microbiol. 44, 649-688.
12. Chen, W., Kawano, H., Men, R., Clark, D. and Lai, C. J. (1995) Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J. virol. 9, 5186-5190.
13. Chen, Y., Maguire, T., Hileman, R.E., Fromm, J.R., Esko, J.D., Linhardt, R.J. and Marks, R.M. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulphate. Nat. Med. 3, 866-871.
14. Craighead, J.E., Sather, G.E., Mammon, W.M. and Dammin, G.J. (1966) Pathology of dengue virus infections in mice. Archives of Pathology 81, 231-239.
15. Daughaday, C.C., Brandt, W.E., Mc Gown, J.M. and Russel, P.K. (1981) Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin- sensitive virus receptors and trypsin-resistant immune complex receptors. Infect. Immun. 32, 469-473.
16. Dietzschold, B., Wang, H., Rupprecht, C., Celis, E., Tollis, M. and Koprowski, H. (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc. Natl. Acad. Sci. USA. 84 (24), 9165-9169.
17. Elbein, A.D. (1984) Inhibitors of the biosynthesis and processing of N-linked oligosaccharides. Rev. Biochem. 16, 21-49.
18. Fonseca, B.A.L., Pincus, S., Shope, R.E., Paoletti, E. and Mason, P.W. (1994). Recombinant vaccinica viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 12, 279-285.
19. Fraser, H.S., Wilson, W.A., Rose, E., Thomas, E.J. and Sissons, J.G.P. (1978) Dengue fever in Jamaica with shock and hemmorhagic and neurological complications. West Indian Med. Journal 27, 106-116.
20. Fu, J., Tan, B., Yap, E., Chan, Y. and Tan, Y. (1992) Full-length cDNA sequence of dengue type 1 virus. Virology 183, 953-958.
21. Fuller, S.D., Berriman, J.A., Butcher, S.J. and Gowen, B.E. (1995) Low pH induces swiveling of the glycoprotein heterodimers in the Semiliki Forest Virus spike complex. Cell 81, 715-725.
22. Germi, R., Jean-Marc Crance, Daniel, Garin., Josette Guimet, Hugues Lortat-Jacob., Rob, W.H., Ruigrok, Jean-Pierre Zarski, and Emmanuel Drouet (2002) Heparan sulphate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292, 162-168.
23. Gollins, S.W. and Porterfield, J.S. (1985) Flavivirus entry and enhancement in macrophages: an electron microscope study of virus and cellular entry. J. Gen. Virol. 66, 1969
24. Gollins, S.W. and Porterfield, J.S. (1986) A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature 321, 244-246.
25. Gubler, D.J., Suharyono, W., Tan, R., Abidin, M. and Sie, A. (1981) Viremia in patients with naturally acquired dengue infection. Bull. World Health Organ. 59, 623-630.
26. Gubler, D.J., Suharyono, W., Lubis, I., Eram, S. and Saroso, J.S. (1979) Epidemic dengue hemorrhagic fever in rural Indonesia I. Virological and epidemiological studies. An. J. Trop. Med. Hyg. 59, 623-630.
27. Gubler, D.J., Kuno, G., Sather, G.E., Velez, M. and Oliver, A. (1984). Mosquito cell cultures and specific monoclonal antbodies in surveillance for dengue viruses. Am. J. Trop. Med. Hyg. 33, 158-165.
28. Guirakhoo, F., Heinz, F.X., Mandl, C.W., Holzmann, H. and Kunz, C. (1991) Fusion activity of flaviviruses. J. Gen. Virol. 72, 1323-1329.
29. Guirakhoo, F. and Roehrig, J.T. (1994) The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203, 241-249.
30. Halstead, S.B. (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239, 476-486.
31. Halstead, S.B. (1983) Comparison of P388 Di mouse macrophage cell line. Am. J. Trop. Med. Hyg. 32, 157-163.
32. Hase, T., Summers, P.L. and Eckels, K.H. (1989) Flavivirus entry into cultured mosquito cells and human perepheral blood monocytes. Arch. Virol. 104, 129-143.
33. Helenius, A. (1995) Alphavirus and flavivirus glycoproteins: structures and functions. Cell 81, 651-653.
34. Holmberg, S.D. (1981) 'Drug-resistant Salmonella from animals fed antimicrobials', New England Journal of Medicine 311, 617-622.
35. Holmes, E.C., Twiddy, S.S. (2003) The origin, emergence and evolutionary genetics of dengue virus. Infect. Genet. E. 3, 19-28.
36. Hung, Shang-Ling, Pei-Lun, Lee, Hsiao-Wang, Chen, Li-Kuang, Chen, Chuan-Liang, Kao and Chwan-Chuen, King (1999) Analysis of the steps involved in dengue virus entry into host cells. Virol. 257, 156-167.
37. Igarashi, A. (1978) Isolation of singh's Aedes albopictus cell clone sensitive to dengue and Chikungunya viruses. J. Gen. Virol. 40: 531-544.
38. Imbert, J. L., Guevara, P., Ramos-Castaneda J., Ramos C. and Sotelo, J. (1994) Dengue virus infects mouse-cultured neurons but not astrocytes. J. Med. Virol. 42, 228-233.
39. Johnson, A.J. and Roehrig, J.T. (1999) New mouse model for dengue virus vaccine testing. J. Virol. 73, 783-786.
40. Kaplan, A.M. and Koveleski, J.T. (1978). St. Louis encephalitis with particular involvement of brain stem. Archives of Neurology 35, 45-46.
41. Kawano, H., Rostapshov, V., Rosen, L. and Lai, C.J. (1993). Genetic determinants of dengue type 4 virus neurovirulence for mice. J. Virol. 67, 6576-6575.
42. Kielian, M.C. and Helenius. (1986) A "Role of cholesterol in fusion of Semliki Forest virus with membranes" J. Virol. pp. R565-R569.
43. Killen, H. and O'Sullivan, M. A. (1993) Detection of dengue virus by insitu hybridization. J. Virol. Methods 41, 3183-3186.
44. King Christine, A., Robert, Anderson and Marshall, J.S. (2002) Dengue virus selectively induces human mast cell chemokine production. J. Gen. Virol. 76, 8408-8419.
45. Kurane, A., Okamoto, Y., Chen Dai, Li., Zeng, L.L., Brinton, M.A. and Ennis, F.A. (1995) Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8-cytotoxic T lymphocyte clones. J. Gen. Virol. 76, 2243-2249.
46. Kurane, I., Janus, J. and Ennis, F.A. (1992) Dengue virus infection of human skin fibroblasts: in vitro production of IFN-beta, IL-6 and GM-CSF. Arch. Virol. 124, 21-30.
47. Lorenz, L., Beaty, B.J., Aitken, T.H., Wallis, G.P. and Tabachnick, W.J. (1984) The effect of colonization upon Aedes aegypti susceptibility to oral infection with yellow fever virus. Am. J. Trop. Med. Hyg. 33, 690-694.
48. Mady, B.J., Kurane, I., Erbe, D.V. and Fanger, M.W. (1993). Neuraminidase augments Fcg receptor II mediated antibody-dependent enhancemept of dengue virus infection. J. Gen. Virol. 74, 839-844.
49. Marianneau, Philippe., Francoise, Megret, Rene, Olivier, David, M., Morens and Vincen, Deubel (1996) Dengue 1 virus binding to human hepatoma HepG2 and simian vero cell surfaces differs. J. Gen. Virol. 77, 2547-2554.
50. Martinez-Barragan, Jose, de. J. and Angel, Rosa M. del. (2001) Identification of a putative coreceptor on vero cells that participates in dengue 4 virus infection. J. Virol. 7818-7827.
51. Marsh, M. and Heleniust, A. (1989). Virus entry into animal cells. Rev. Adv. Virus Res. Vol. 36, Acad. Press.
52. Mason, P. W., Pincus, S., Fournier, M.J., Mason, T.L. and Paoletti, E. (1991) Japanese encephalitis virus-vaccinia recombinants produce particulate forms of structural membrane proteins and induce high levels of protection against JEV infection. Virology 180, 294-305.
53. Monath, T.P. (1994) Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91, 2395-2400.
54. Monath, T.P. (1989) Pathobiology of the flavivirus: New York: Plenum Press, pp 375-441.
55. Monath, T.P. (1990) Flaviviruses. In Fields of Virology, 2nd edition. 763-814. Lippincott-Raven, Philadelphia.
56. Monath, T. P. and Heinz, F.X. (1996) Flaviviruses. In fields of Virology. (eds) 3rd edition pp 961-1034. Lippincott-Raven, Philadelphia.
57. Okamoto, Y., Gagnon, S.J., Kurane, I., Leporati, A.M. and Ennis, F.A. (1994) Preferential usage of T-cell receptor by dengue virus specific human T lymphocytes in a donor with immunity to dengue virus type 4. J. Virol. 68, 7614-7619.
58. Oldstone, M.B.A., Lewicki, H., Thomas, D., Tishon, A., Dales, S., Patterson, J., Manchester, M., Homann, D., Naniche, D. and Holz, A. (1999) Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 98, 629-640.
59. Peiris, J.S. and Porterfield, J.S. (1979). Antibody-mediated enhancement of flavivirus replication in macrophage-like cell lines. Virology 359, 10-24.
60. Peiris, J.S., Weiss, R.C. and Scott, F.W. (1981) Antibody mediated enhancement of viral infection. 8, 103-117.
61. Rey, F.A., Heinz, F.X., Mandi, C., Kunz, C. and Harrison, S.C. (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375, 291-298.
62. Rice, C.M. (1996) Flaviviridae: the viruses and their replication (Fields virology). Lippincott-Raven, Philadelphia, pa. 931-950.
63. Salas-Benito, J. S. and Angel Rosa M. del. (1997) Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. J. Virol. 71, 7246-7252.
64. Sanchez, I.J. and Ruiz, B.H. (1996). A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain effects neurovirulence in mice. J. Gen. Virol. 77, 2541-2545.
65. Smith, G. W. and Wright, P.J. (1985) Synthesis of proteins and glycoproteins in dengue type 2 virus infected Vero and Aedes albopictus cells. J. Gen. Virol. 66, 559-571.
66. Sommerfelt, M.A. and Marsh (1988) Human T-cell leukaemia viruses types 1 and 2 utilise a common receptor encoded by human chromosome 17. Science 242, 1557-1559.
67. Sumarmo, W.H., Jahja, E., Gubler, D.J., Sutomengolo, T.S. and Soroso, J.S. (1978) Encephalopathy associated with dengue infection. Lancet 25, 449-450.
68. Suri, K. and Banerjee, K. (1987). Growth characteristics of Japanese encephalitis, WV, and dengue 2 viruses in embryonic mouse brain cell cultures. Indian J. Med. Res. 86, 148-161.
69. Tassaneetrithep, B., Burgess, T.H., Granelli-piperno, A., Tsrumptheller, C., Jennifer Finke, Wellington Sun, Michael, A.E., Pattanapanyasat, K., Sarasombath, S., Deborah, L., Birx, R.M., Steinman, Schlesinger, S. and Mary A.M. (2003) DC-SIGN (CD209) mediates dengue virus infection of Human dendritic cells. J. Exptl. Med. 197 (7), 823-829.
70. Tulsani, D.R.P., Harris, T.M. and Touster, O. (1989). Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II. J. Biol. Chem. 257, 7936-7939.
71. Vazeille, M., Rosen, L., Mousson, L. and Failloux, A.B. (2003) Low oral receptivity for dengue type 2 viruses of Aedes albopictus from Southeast Asia compared with that of Aedes aegypti. Am. J. Trop. Med. Hyg. 68, 203-208.
72. Wang, Songli., He, Runtao., Jintana Patarapotikul., Innis, B. L. and Robert Anderson (1995) Antibody-enhanced binding of dengue-2 virus to human platelets. J. Virol. 254-257.
73. Wang, Songli., He, Runtao and Robert Anderson (1999) PrM and cell-binding domains of the dengue virus E protein. J. Virol. 73, 2547-2551.
74. Wei, H.Y., Jiang, L.F., Fang, D.Y. and Guo, H.Y. (2003) Dengue virus type 2 infects human endothelial cells through binding of the viral env glycoprotein to cell surface polypeptides. J. Gen. Virol. 84, 3095-3098.
75. Wilson, M.E., Levins, R. and Spielman, A. (1994) Disease in evolution: global changes and emergence of infectious diseases. New York: New York Academy of Sciences, 740.
76. Wilson, M.E. (1991) A world guide to infections: diseases, distribution, diagnosis. New York: Oxford University Press.
77. World Health Organization (1999) Dengue Haemorrhagic Fever: Diagnosis, Treatment and Control. Geneva.
78. Wu, S.J.L., Hayes, G.G., Dubois, D.R., Windheuser, M.G., Kang, Y.H., Watts, D.M. and Siegkmann, D.G. (1995) Evaluation of severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am. J. Trop. Med. Hyg. 52, 468-476.
79. Wu, J.C., Chiang, T.Y. and Sheen, I.J. (1998) Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J. Gen. Virol. 79, 1105-1113.
80. Yasumura, Y. and Kawakita, A. (1963) Studies on SV-40 in tissue culture. Nippon Rinsho 21, 1201-1219.
81. Zeng Lingling, Kurane, I., Okamoto, Y. and Ennis, F.A. (1996) Identification of aminoacids involved in recognition by dengue virus NS3-Specific, HLA-DR15-Restricted cytotoxic CD4+ T-cell clones. J. Virol. 7, 3108-3117.